China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Arm Study on the Efficacy and Safety of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130366
Registration Time: 2026/08/19
Type: Interventional study
Primary Sponsor: West China Hospital of Sichuan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331956
Published by HT Digital Content Services with permission from Health Daily Digest....